Search

Your search keyword '"DI LILLO, Cristina"' showing total 3 results
Start Over Author "DI LILLO, Cristina"
3 results on '"DI LILLO, Cristina"'

1. Quality of Life in Older Adults After Major Cancer Surgery: The GOSAFE International Study

Author

Montroni, Isacco, Ugolini, Giampaolo, Saur, Nicole M, Rostoft, Siri, Spinelli, Antonino, Van Leeuwen, Barbara L, De Liguori Carino, Nicola, Ghignone, Federico, Jaklitsch, Michael T, Somasundar, Ponnandai, Garutti, Anna, Zingaretti, Chiara, Foca, Flavia, Vertogen, Bernadette, Nanni, Oriana, Wexner, Steven D, Audisio, Riccardo, A Giovanni Taffurelli, Davide, Zattoni, Paola, Tramelli, Giacomo, Sermonesi, Giorgio, Ercolani, Francesca, Tauceri, Barbara, Perenze, Daniela Di Pietrantonio, Mariateresa, Mirarchi, Gianluca, Garulli, Vincenzo, Alagna, Lucchi, Andrea, Basilio, Pirrera, Francesco, Monari, Luigi, Conti, Patrizio, Capelli, Andrea, Romboli, Gerardo, Palmieri, Filippo, Banchini, Francesca Di Candido, Michele, Carvello, Matteo, Sacchi, DE LUCIA, Francesca, Caterina, Foppa, Luigi, Marano, Spaziani, Alessandro, Giampaolo, Castagnoli, Bartoli, Alberto, Laura, Frain, Sam, W Fox, Kristin, Cardin, Luis, E De Leon, Mario, Trompetto, Gallo, Gaetano, Alberto Realis Luc, Giuseppe, Clerico, Giuseppe, Sammarco, Raffaele De Luca, Michele, Simone, Rocco, Lomonaco, Michael, Fejka, Joshua I, S Bleier, Matthijs, Plas, Hanneke van der Wal-Huisman, Andrea, Costanzi, Giulio, Mari, Dario, Maggioni, Pellegrino, Roberta, Pietro, Ascheri, Jakub, Kenig, Kinga, Szabat, Stefano, Scabini, Davide, Pertile, Lorenzo, Epis, Andrea, Massobrio, Domenico, Soriero, Arild, Nesbakken, Ingeborg Flåten Backe, Mariann, Lønn, Ferrari, Giovanni, Michele, Mazzola, Carmelo, Magistro, Pietro, Achilli, Alessandro, Giani, Orestis, Ioannidis, Lydia, Loutzidou, Konstantinos, Galanos-Demiris, Balducci, Genoveffa, Frezza, Barbara, Lucarini, Alessio, Claudia, Santos, Diogo, Cardoso, Isabela, Gil, Vasco, Cardoso, Lisa, Cooper, Baha, Siam, Yochai, Levy, Baruch, Brenner, Hanoch, Kashtan, Valerio, Belgrano, Franco, Decian, Beatrice, Palermo, Roberto, Eggenhöffner, Manuela, Albertelli, Luis, Sánchez-Guillén, Antonio, Arroyo, Francisco, López-Rodríguez, Sandra, Lario, DI LILLO, Cristina, Minas, Baltatzis, Anthony K, C Chan, Ajith, K Siriwardena, Giovanna Da Silva, Guided Treatment in Optimal Selected Cancer Patients (GUTS), and Damage and Repair in Cancer Development and Cancer Treatment (DARE)

Subjects
Cancer Research, aged, Oncology, male, quality of life, geriatric assessment, 80 and over, neoplasms, pain, frailty, humans, aged, 80 and over
Abstract

Background Accurate quality of life (QoL) data and functional results after cancer surgery are lacking for older patients. The international, multicenter Geriatric Oncology Surgical Assessment and Functional rEcovery after Surgery (GOSAFE) Study compares QoL before and after surgery and identifies predictors of decline in QoL. Methods GOSAFE prospectively collected data before and after major elective cancer surgery on older adults (≥70 years). Frailty assessment was performed and postoperative outcomes recorded (30, 90, and 180 days postoperatively) together with QoL data by means of the three-level version of the EuroQol five-dimensional questionnaire (EQ-5D-3L), including 2 components: an index (range = 0-1) generated by 5 domains (mobility, self-care, ability to perform the usual activities, pain or discomfort, anxiety or depression) and a visual analog scale. Results Data from 26 centers were collected (February 2017-March 2019). Complete data were available for 942/1005 consecutive patients (94.0%): 492 male (52.2%), median age 78 years (range = 70-95 years), and primary tumor was colorectal in 67.8%. A total 61.2% of all surgeries were via a minimally invasive approach. The 30-, 90-, and 180-day mortality was 3.7%, 6.3%, and 9%, respectively. At 30 and 180 days, postoperative morbidity was 39.2% and 52.4%, respectively, and Clavien-Dindo III-IV complications were 13.5% and 18.7%, respectively. The mean EQ-5D-3L index was similar before vs 3 months but improved at 6 months (0.79 vs 0.82; P Conclusions GOSAFE shows that older adults’ preoperative QoL is preserved 3 months after cancer surgery, independent of their age. Frailty screening tools, patient-reported outcomes, and goals-of-care discussions can guide decisions to pursue surgery and direct patients’ expectations.

Published
2022

2. Severe combined immunodeficiency-an update

Author

CIRILLO, EMILIA, GIARDINO, GIULIANA, GALLO, VERA, D'ASSANTE, ROBERTA, GRASSO, FIORENTINO, Romano, Roberta, Di Lillo, Cristina, Galasso, Giovanni, PIGNATA, CLAUDIO, Cirillo, Emilia, Giardino, Giuliana, Gallo, Vera, D'Assante, Roberta, Grasso, Fiorentino, Romano, Roberta, Di Lillo, Cristina, Galasso, Giovanni, and Pignata, Claudio

Subjects
Primary immunodeficiency, Severe combined immunodeficiency, Nude/SCID, SCID, DiGeorge syndrome, Cytokine, Thymus
Abstract

Severe combined immunodeficiencies (SCIDs) are a group of inherited disorders responsible for severe dysfunctions of the immune system. These diseases are life-threatening when the diagnosis is made too late; they are the most severe forms of primary immunodeficiency. SCID patients often die during the first two years of life if appropriate treatments to reconstitute their immune system are not undertaken. Conventionally, SCIDs are classified according either to the main pathway affected by the molecular defect or on the basis of the specific immunologic phenotype that reflects the stage where the blockage occurs during the differentiation process. However, during the last few years many new causative gene alterations have been associated with unusual clinical and immunological phenotypes. Many of these novel forms of SCID also show extra-hematopoietic alterations, leading to complex phenotypes characterized by a functional impairment of several organs, which may lead to a considerable delay in the diagnosis. Here we review the biological and clinical features of SCIDs paying particular attention to the most recently identified forms and to their unusual or extra-immunological clinical features.

Published
2015

3. Severe combined immunodeficiency--an update.

Author

Cirillo E, Giardino G, Gallo V, D'Assante R, Grasso F, Romano R, Di Lillo C, Galasso G, and Pignata C

Subjects
Humans, Severe Combined Immunodeficiency epidemiology, Severe Combined Immunodeficiency pathology, Severe Combined Immunodeficiency classification, Severe Combined Immunodeficiency diagnosis, Severe Combined Immunodeficiency genetics, Severe Combined Immunodeficiency immunology
Abstract

Severe combined immunodeficiencies (SCIDs) are a group of inherited disorders responsible for severe dysfunctions of the immune system. These diseases are life-threatening when the diagnosis is made too late; they are the most severe forms of primary immunodeficiency. SCID patients often die during the first two years of life if appropriate treatments to reconstitute their immune system are not undertaken. Conventionally, SCIDs are classified according either to the main pathway affected by the molecular defect or on the basis of the specific immunologic phenotype that reflects the stage where the blockage occurs during the differentiation process. However, during the last few years many new causative gene alterations have been associated with unusual clinical and immunological phenotypes. Many of these novel forms of SCID also show extra-hematopoietic alterations, leading to complex phenotypes characterized by a functional impairment of several organs, which may lead to a considerable delay in the diagnosis. Here we review the biological and clinical features of SCIDs paying particular attention to the most recently identified forms and to their unusual or extra-immunological clinical features., (© 2015 New York Academy of Sciences.)

Published
2015
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results